Searchable abstracts of presentations at key conferences in endocrinology

ea0065p58 | Adrenal and Cardiovascular | SFEBES2019

Safe withdrawal of corticosteroids after prolonged use: a call for a national protocol

Nawaz Zahrah , Sorungbe Adebola O , Rajkanna Jeyanthy , Seechurn Shivshankar B , Sagi Satyanarayana V , Oyibo Samson O

Introduction: Prolonged therapy with high-dose corticosteroids (≥ 7.5 mg Prednisolone or 1–1.5 mg Dexamethasone daily) can result in adrenal atrophy and hypofunction. Abrupt withdrawal of corticosteroids after prolonged use can lead to adrenal insufficiency, corticosteroid withdrawal symptoms or a relapse of the initial disease. There are several in-house protocols for safe corticosteroid dose tapering but a national protocol is required.Our p...

ea0065p430 | Thyroid | SFEBES2019

Iododerma following radioiodine treatment for Graves’ thyrotoxicosis

Sorungbe Adebola O , Nwabufor Philip C , Rajkanna Jeyanthy , Sagi Satyanarayana V , Oyibo Samson O

Introduction: Iododerma is a hypersensitive skin reaction that occurs after exposure to Iodine. It is a well-known adverse reaction after intravenous iodine-containing contrast medium, but cases occurring after oral exposure are rare. A six-year follow-up study in one centre looking for any skin lesions occurring after oral radioiodine therapy for thyrotoxicosis, noted an incidence rate of 2.1% in 141 patients. The skin lesions can be acneiform, erythematous, urticarial, hemor...